Eckert & Ziegler
XTRA:EUZ Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 19 Fair Values set on narratives written by author
WA
Consensus Narrative from 1 Analyst
European GalliaPharm Approval And Telix Partnership Will Open New Markets And Strengthen Future Prospects
Key Takeaways European market expansion via GalliaPharm approval and strategic partnerships drive new revenue streams and improved earnings potential. Investment in CMO facilities and new isotope growth positions enhance future profitability and market expansion opportunities.
View narrative€66.00
FV
8.3% undervalued intrinsic discount9.68%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
12 days ago author updated this narrative